Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxiconazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 6/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 4/20 | 1.00 |
| ▸ | PGR | P06401 | 3/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 3/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 3/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 3/20 | 1.00 |
| ▸ | ADRB3 | P13945 | 3/20 | 1.00 |
| ▸ | IDO1 | P14902 | 3/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 3/20 | 1.00 |
| ▸ | CHRM3 | P20309 | 3/20 | 1.00 |
| ▸ | TACR2 | P21452 | 3/20 | 1.00 |
| ▸ | DRD1 | P21728 | 3/20 | 1.00 |
| ▸ | ACHE | P22303 | 3/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 3/20 | 1.00 |
| ▸ | TBXAS1 | P24557 | 3/20 | 1.00 |
| ▸ | HTR2A | P28223 | 3/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 3/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxiconazole SCHEMBL30416587 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| Oxiconazole SCHEMBL34518 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| Oxiconazole SCHEMBL4540297 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| Oxiconazole SCHEMBL601577 | 0.99 | CYP3A4 (0.98) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| Oxiconazole SCHEMBL21180321 | 0.99 | CYP3A4 (0.98) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| Oxiconazole SCHEMBL18916735 | 0.94 | CYP3A4 (0.88) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| SCHEMBL18309812 | 0.94 | IDO1 (0.88) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| Oxiconazole SCHEMBL18916734 | 0.94 | CYP3A4 (0.88) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| Oxiconazole SCHEMBL153416 | 0.93 | CYP3A4 (1.00) | CYP3A4CYP2C9CYP2D6CYP2C19PGR | |
| Oxiconazole SCHEMBL153417 | 0.93 | CYP3A4 (1.00) | CYP3A4CYP2C9CYP2D6CYP2C19PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 12197 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106952-A1 | METHODS FOR TREATING CONGENITAL DISORDERS OF GLYCOSYLATION | CDG CARE (US) | 2026-05-21 | — | — | WO | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260102419-A1 | USE OF COMPOUNDS IN THE TREATMENT OF FUNGAL INFECTIONS | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2026-04-16 | — | — | US | claimed |
| EP-4719384-A2 | COMPOUNDS WITH ANTIFUNGAL PROPERTIES | Trustees of Dartmouth College (US) | 2026-04-08 | — | — | EP | claimed |
| US-20260027140-A1 | COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA | ATOPIC MEDICAL INC (US) | 2026-01-29 | — | — | US | claimed |
| EP-4680240-A1 | METHOD OF TREATING DISORDERS WITH SURF1 MALFUNCTION | Cure Mito Foundation (US) | 2026-01-21 | — | — | EP | claimed |
| EP-4676500-A2 | MICROBIAL CONSORTIA | Kanvas Biosciences, Inc (US) | 2026-01-14 | — | — | EP | claimed |
| US-20260007753-A1 | DERMAL SKIN PROTECTANT AND CARRIER | INSPIRED MAT STRATEGIES LLC (US) | 2026-01-08 | — | — | US | claimed |
| US-12465592-B2 | Structured encapsulated silicon-containing particles | SISAF LIMITED (GB) | 2025-11-11 | — | — | US | claimed |
| US-12458523-B2 | Nail correction kit | NEUBOURG SKIN CARE GMBH (DE) | 2025-11-04 | — | — | US | claimed |
| US-4861580-A | Composition using salt form of organic acid derivative of alpha-tocopheral | THE LIPOSOME COMPANY, INC. (US) | 1989-08-29 | — | — | US | claimed |
| EP-0310122-A1 | Antifungal composition | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1989-04-05 | — | — | EP | claimed |
| EP-0243446-A4 | ALPHA TOCOPHEROL-BASED VESICLES. | LIPOSOME CO INC (US) | 1988-06-23 | — | — | EP | claimed |
| EP-0222771-A4 | STEROIDAL LIPOSOMES. | LIPOSOME CORP (US) | 1988-06-08 | — | — | EP | claimed |
| EP-0243446-A1 | ALPHA TOCOPHEROL-BASED VESICLES. | LIPOSOME CO INC (US) | 1987-11-04 | — | — | EP | claimed |
| EP-0222771-A1 | STEROIDAL LIPOSOMES | THE LIPOSOME COMPANY, INC. (US) | 1987-05-27 | — | — | EP | claimed |
| WO-1987002219-A1 | ALPHA TOCOPHEROL-BASED VESICLES | THE LIPOSOME COMPANY, INC. (US) | 1987-04-23 | — | — | WO | claimed |
| WO-1986005977-A1 | STEROIDAL LIPOSOMES | THE LIPOSOME COMPANY, INC. (US) | 1986-10-23 | — | — | WO | claimed |
| EP-0005794-B1 | A PROCESS FOR THE STEREO-SPECIFIC OR STEREO-SELECTIVE PREPARATION OF IMIDAZOLYL-OXIME ETHER DERIVATIVES AND IMIDAZOLYL-OXIME DERIVATIVES | SIEGFRIED AKTIENGESELLSCHAFT (CH) | 1983-01-05 | — | — | EP | claimed |
| US-4124767-A | Imidazolyl-oxime ethers having anti-mycotic and bactericidal activity | SIEGFRIED A.G. (CH) | 1978-11-07 | — | — | US | claimed |